Look out below. Also, they claim to not being able to release trial news due to patent concerns. This is an admission that they can't patent natural substances, and anything successful can be easily copied and marketed in competition.
Raising will have to be at a significant discount to the current market price. Add dilution to this, and it could be a bloodbath.
No news on Ropren approval. Interesting.
Look out below. Also, they claim to not being able to release...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)